How much does Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets) Cost& price without insurance in China?
Sifrol® is the commercial brand name of Pramipexole Dihydrochloride Sustained-Release Tablets, an orally active non-ergot dopamine agonist developed by Boehringer Ingelheim. It stimulates dopamine receptors to improve motor symptoms and related complications of Parkinson’s disease.
Main Indications
Treatment of idiopathic Parkinson’s disease (PD), including early-stage monotherapy and combination therapy with levodopa in advanced stages.
Common Side Effects
Common mild adverse reactions: Nausea, dizziness, somnolence, insomnia and constipation.
Laboratory abnormalities: Rare transient blood pressure fluctuation.
Severe but uncommon risks: Orthostatic hypotension, pathological gambling/compulsive behaviors, hallucinations and sudden sleep attacks.
Approval Status in China
Sifrol® (Pramipexole Dihydrochloride Sustained-Release Tablets, 0.75mg) was officially approved for marketing in China in 2007. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
